BioSpace News Archive

Stimwave Technologies, Inc., a global medical device company that provides minimally invasive, MRI-compatible, battery-free implantable devices to treat chronic pain, today announced the settlement of Nevro’s patent infringement lawsuit.

Encompass Health Corp. announced it has purchased land near the 4900 block of 12th Ave. in Pensacola, Florida with plans to build a 40-bed inpatient rehabilitation hospital to serve patients recovering from debilitating illnesses and injuries.

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced that the upcoming 8.5 edition of its industry-leading LabVantage platform will include the first fully integrated Scientific Data Management System (SDMS).

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held on Tuesday March 3, 2020 at 8:00 AM ET to discuss results for the fourth quarter and year-end 2019 and provide a business outlook for 2020

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on February 29 it is joining the European Organisation for Rare Diseases (EURORDIS) and the National Organization for Rare Disorders (NORD) to recognize Rare Disease Day®, an international campaign elevating the public understanding of rare diseases.

KemPharm, Inc. (Nasdaq: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today provided an update on the KP415 NDA and reported its financial results for the fourth quarter and full-year ended December 31, 2019.

Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the treatment of serious chronic diseases, today announced that Praveen Tipirneni, M.D., president and chief executive officer of Morphic Therapeutic, is scheduled to present at the 40th Annual Cowen Health Care Conference at 8:00 AM ET on Wednesday, March 4, 2020

Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call and audio webcast on Friday, March 6, 2020 at 8:30 a.m. ET to report financial results for the fourth quarter and full year ended December 31, 2019 and to provide a business overview.

Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, today announced that management will present a corporate overview at the Cowen & Company 40th Annual Health Care Conference,

Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Mark Pruzanski, M.D., President and Chief Executive Officer of Intercept, will present at the Cowen 40th Annual Health Care Conference in Boston on Tuesday, March 3, 2020 at 8:00 a.m. ET.